Clinical Trial: Diltiazem in Jervell and Lange-Nielsen Syndrome
Study Status: COMPLETED
Recruit Status: COMPLETED
Condition: Jervell and Lange Nielsen Syndrome
Study Type: INTERVENTIONAL
Official Title: Diltiazem in Jervell and Lange-Nielsen Syndrome
Brief Summary:
This study will test the effect of diltiazem, a calcium channel blocking drug, on the QT interval in patients with Jervell and Lange-Nielsen syndrome.This will be a single IV dose and acute effects (within minutes) will be observed.
Read more